Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia Clinical Trials in Philadelphia, Pennsylvania

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)